Allena Pharmaceuticals, Inc.
SEC CIK 1624658 · ALNA · last insider filing 2022-02-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Brenner Louis MD | Director · See Remarks | filed 2017 - 2022 |
| Santini Gino | Director | filed 2017 - 2021 |
| Margolin Alexey L | Director · Chief Executive Officer | filed 2017 - 2021 |
| Alexander Robert | Director | filed 2017 - 2021 |
| Miller Ann Calby | Director | filed 2020 - 2021 |
| Diaz Allene M. | Director | filed 2019 - 2021 |
| Fitzpatrick Mark J. | Director | filed 2021 - 2021 |
| Topper James N | Director | filed 2017 - 2020 |
| Hack Andrew A. F. | Director | filed 2018 - 2020 |
| Tepper Robert I | Director | filed 2017 - 2019 |
| Bolte Axel | Director | filed 2017 - 2018 |
| Kraus Stephen | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Katz Richard D | Chief Financial Officer | filed 2021 - 2022 |
| Wholihan Edward | Chief Financial Officer | filed 2017 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.